Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atul Pathak

Showing results (81-90 of 200) with videos related to

Pageof 20
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 21, 2016
Will SPRINT change my practice? SPRINT: a randomised trial of intensive versus standard blood-pressure controlSebastian Ewen, Melvin D Lobo, Atul Pathak, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 29, 2010
High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patientsNeda Tavassoli, Sophie Voisin, Didier Carrie, et al.
Journal of Hypertension|August 11, 2020
Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertensionRoland E Schmieder, David E Kandzari, Tzung-Dau Wang, et al.
Vascular Health and Risk Management|April 7, 2016
Prevalence and correlates of coronary heart disease: first population-based study in LebanonRouba Karen Zeidan, Rita Farah, Mirna N Chahine, et al.
Clinical Hypertension|July 15, 2016
Prognostic value of systolic short-term blood pressure variability in systolic heart failureMatthieu Berry, Olivier Lairez, Joelle Fourcade, et al.
Bioconjugate Chemistry|January 18, 2007
N-(Iodoacetyl)-N'-(anthraquinon-2-oyl)-ethylenediamine (IAED): a new heterobifunctional reagent for the preparation of biochipsSatyakam Patnaik, Archana Swami, Dalip Sethi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 14, 2020
The interplay between cardiology and diabetology: a renewed collaboration to optimize cardiovascular prevention and heart failure managementPierre Sabouret, Giuseppe Galati, Denis Angoulvant, et al.
Presse Medicale (Paris, France : 1983)|March 27, 2013
[Management of arterial hypertension in adults: 2013 guidelines of the French Society of Arterial Hypertension]Jacques Blacher, Jean-Michel Halimi, Olivier Hanon, et al.
Journal of Hypertension|December 14, 2019
Medication adherence in hypertensionNeil R Poulter, Claudio Borghi, Gianfranco Parati, et al.
Fundamental & Clinical Pharmacology|November 5, 2011
Design and methodology of POWER, an open-label observation of the effect of primary care interventions on total cardiovascular risk in patients with hypertensionGuy De Backer, Robert J Petrella, Assen R Goudev, et al.
Pageof 20

Showing results (81-90 of 200) with videos related to

Sort By:
Pageof 20
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 21, 2016
Will SPRINT change my practice? SPRINT: a randomised trial of intensive versus standard blood-pressure controlSebastian Ewen, Melvin D Lobo, Atul Pathak, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 29, 2010
High maintenance dosage of clopidogrel is associated with a reduced risk of stent thrombosis in clopidogrel-resistant patientsNeda Tavassoli, Sophie Voisin, Didier Carrie, et al.
Journal of Hypertension|August 11, 2020
Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertensionRoland E Schmieder, David E Kandzari, Tzung-Dau Wang, et al.
Vascular Health and Risk Management|April 7, 2016
Prevalence and correlates of coronary heart disease: first population-based study in LebanonRouba Karen Zeidan, Rita Farah, Mirna N Chahine, et al.
Clinical Hypertension|July 15, 2016
Prognostic value of systolic short-term blood pressure variability in systolic heart failureMatthieu Berry, Olivier Lairez, Joelle Fourcade, et al.
Bioconjugate Chemistry|January 18, 2007
N-(Iodoacetyl)-N'-(anthraquinon-2-oyl)-ethylenediamine (IAED): a new heterobifunctional reagent for the preparation of biochipsSatyakam Patnaik, Archana Swami, Dalip Sethi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 14, 2020
The interplay between cardiology and diabetology: a renewed collaboration to optimize cardiovascular prevention and heart failure managementPierre Sabouret, Giuseppe Galati, Denis Angoulvant, et al.
Presse Medicale (Paris, France : 1983)|March 27, 2013
[Management of arterial hypertension in adults: 2013 guidelines of the French Society of Arterial Hypertension]Jacques Blacher, Jean-Michel Halimi, Olivier Hanon, et al.
Journal of Hypertension|December 14, 2019
Medication adherence in hypertensionNeil R Poulter, Claudio Borghi, Gianfranco Parati, et al.
Fundamental & Clinical Pharmacology|November 5, 2011
Design and methodology of POWER, an open-label observation of the effect of primary care interventions on total cardiovascular risk in patients with hypertensionGuy De Backer, Robert J Petrella, Assen R Goudev, et al.
Pageof 20